Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 13:14:897674.
doi: 10.3389/fnagi.2022.897674. eCollection 2022.

MRI Markers of Small Vessel Disease and the APOE Allele in Cognitive Impairment

Mana Shams  1   2 , Sara Shams  1   2 , Juha Martola  1   2 , Lena Cavallin  1   2 , Tobias Granberg  1   2 , Magnus Kaijser  1   2 , Max Wintermark  3 , Eric Westman  4   5 , Peter Aspelin  1   2 , Maria Kristoffersen Wiberg  1   2 , Lars-Olof Wahlund  4   5
Affiliations

MRI Markers of Small Vessel Disease and the APOE Allele in Cognitive Impairment

Mana Shams et al. Front Aging Neurosci. .

Abstract

Objective: The apolipoprotein E (APOE) ε4 allele is the main genetic risk factor for dementia and Alzheimer's disease (AD), but the underlying mechanism for the increased risk is not well understood. Cerebral small vessel disease (SVD) is prevalent among patients with cognitive impairment and is thought to play an important role in the pathophysiology of dementia. We aimed to investigate the association between the APOE ε genotype and magnetic resonance imaging (MRI) markers of SVD in a memory clinic population.

Material and methods: This is a cross-sectional study with a total of 520 patients undergoing dementia investigation, including an MRI brain scan and APOE genotyping in all patients enrolled, and cerebrospinal fluid (CSF) analysis for routine AD biomarkers in 399 patients. MR images were assessed for markers of SVD: cerebral microbleeds (CMBs), cortical superficial siderosis, intracerebral hemorrhage, white matter hyperintensities, lacunar infarcts, and enlarged perivascular spaces.

Results: Apolipoprotein E carriers with AD had a higher number of CMBs when looking at all brain regions and lobar brain regions (p < 0.001). A lower number of CMBs were seen in APOE ε2 (p < 0.05), ε3 and ε3/3 carriers (p < 0.001) when looking at all brain regions. A higher number of CMBs in deep and infratentorial regions were seen in APOE ε2 and ε3 (p < 0.05). In APOE ε4/4 carriers, CMBs, cortical superficial siderosis, white matter hyperintensities, and enlarged perivascular spaces were associated with lower levels of CSF amyloid β (Aβ) 42 in the whole cohort, and in individuals with AD and mild cognitive impairment (p < 0.05).

Conclusion: Apolipoprotein E ε4 is associated with MRI markers of SVD related to amyloid pathology, specifically CMBs and Aβ42 plaque formation in the brain, as reflected by decreased CSF Aβ42 levels, whereas APOE ε3 and ε2 are associated with the markers of hypertensive arteriopathy, as reflected by the association with CMBs in deep and infratentorial brain regions.

Keywords: Alzheimer's disease; apolipoprotein E; cerebral amyloid angiopathy; cerebral small vessel disease; dementia; hypertensive vasculopathy; magnetic resonance imaging.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of the participants enrolled in the study. Among the 520 participants included in the analysis, 399 participants had cerebrospinal fluid (CSF) analysis for routine Alzheimer's disease (AD) biomarkers.
Figure 2
Figure 2
Markers of small vessel disease on MRI. (1) Disseminated superficial siderosis on T2*. (2) Cerebral microbleeds (CMBs), as well as white matter hyperintensities on T2*. (3) Enlarged perivascular spaces (EPVS) in the basal ganglia on T2. (4) EPVS in the centrum semiovale on T2 and intracerebral macrohemorrhage with local atrophy in the left parietal lobe.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Braffman B. H., Zimmerman R. A., Trojanowski J. Q., Gonatas N. K., Hickey W. F., Schlaepfer W. W. (1988). Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. AJR Am. J. Roentgenol. 151, 551–558. 10.2214/ajr.151.3.551 - DOI - PubMed
    1. Braun H., Schreiber S. (2013). Microbleeds in cerebral small vessel disease. Lancet Neurol. 12, 735–736. 10.1016/S1474-4422(13)70148-0 - DOI - PubMed
    1. Brickman A. M., Honig L. S., Scarmeas N., Tatarina O., Sanders L., Albert M. S., et al. . (2008). Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch. Neurol. 65, 1202–1208. 10.1001/archneur.65.9.1202 - DOI - PMC - PubMed
    1. Brickman A. M., Provenzano F. A., Muraskin J., Manly J. J., Blum S., Apa Z., et al. . (2012). Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch. Neurol. 69, 1621–1627. 10.1001/archneurol.2012.1527 - DOI - PMC - PubMed
    1. Brickman A. M., Schupf N., Manly J. J., Stern Y., Luchsinger J. A., Provenzano F. A., et al. . (2014). APOE ε4 and risk for Alzheimer's disease: Do regionally distributed white matter hyperintensities play a role? Alzheimers Dement J Alzheimers Assoc 10, 619–629. 10.1016/j.jalz.2014.07.155 - DOI - PMC - PubMed